Ismail 2017.

Methods	Design: RCT Setting: Omdurman Maternity Hospital, Sudan
Participants	Inclusion criteria: women with singleton pregnancies at term (complete 37+0‐39 weeks); under regional anaesthesia, and only women with confirmed dates (early ultrasound scan 1st and 2nd trimester, or sure about LMP) Exclusion criteria: women with DM, women with congenital malformed babies, IUGR, gestation less than 37 weeks, multiple pregnancies, women who received dexamethasone, two doses during pregnancy due to other causes, and women who refused this intervention Number randomised: 560 (281 and 279) Number analysed: A 281, B 279
Interventions	Intervention (n = 281): dexamethasone 12 mg, 12 hours apart 48 hours before elective caesarean section Control (n = 279): no treatment
Outcomes	Apgar score Admission to neonatal unit Development of TTN or RDS Duration of stay in neonatal unit
Notes	Study dates: July 2013 to January 2014 Funding sources: not reported Declarations of interest: not reported We emailed the trial authors on 7 February 2021 to ask for information regarding prospective trial registration, randomisation and number of women lost to follow‐up. Awaiting reply. Not included in 2021 update because of lack of response from trial authors regarding our trustworthiness criteria (trial published since 2010 without prospective registration)